(Q39270649)

English

Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound

scientific article published on April 9, 1979

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound (English)

reason for preferred rank

most precise value

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Decreased antistereotypic effect of neuroliptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

author name string

Scheel-Krüger J

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A. V. Christensen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

J. Arnt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

J. Scheel-Krüger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

language of work or name

0 references

publication date

1 April 1979

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

9 April 1979

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=39205

2 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0024320579900109?httpAccept=text/xml

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

https://api.elsevier.com/content/article/PII:0024320579900109?httpAccept=text/plain

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1395-1402

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Rotational behavior induced in rats by intranigral picrotoxin

1

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Antagonism of Methylphenidate-Induced Stereotyped Gnawing in Mice

3

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Central Effects of Anticholinergic Drugs Measured by the Apomorphine Gnawing Test in Mice

4

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain

6

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice

7

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: A complex GABA-dopamine interaction

8

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra.

9

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral gabaergic pathway

10

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonists

11

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Rotational behaviour after unilateral intranigral injection of muscimol in rats

12

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

GABA-like properties of flurazepam and baclofen suggested by rotational behaviour following unilateral intranigral injection: a comparison with the GABA agonist muscimol [proceedings]

13

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

A new class of GABA agonist

15

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons

18

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Heparin stability in dextrose solutions [proceedings]

20

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Central GABA receptor agonists: Comparison of muscimol and baclofen

21

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

GABA receptor binding with 3H (+) bicuculline–methiodide in rat CNS

22

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Peripheral and central muscarinic receptor affinity of psychotropic drugs

24

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

25

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain

26

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Inhibition by Neuroleptics of Uptake of 3H-GABA into Rat Brain Synaptosomes

27

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

29

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol antagonizes morphine hypermotility without potentiation of analgesia

30

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

31

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol: GABA agonist therapy in schizophrenia

34

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Drug Therapy of Tardive Dyskinesia

35

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Identifiers

10.1016/0024-3205(79)90010-9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39270649&oldid=1763120799"